CLASS II ONGOING Device recall · Reported 3 Nov 2021 · FDA Enforcement Report

Advia Chemistry Urinary/Cerebrospinal Fluid Protein (UCFP) recalled

Siemens Healthcare Diagnostics is recalling Advia Chemistry Urinary/Cerebrospinal Fluid Protein (UCFP), SMN 11319151, distributed nationwide in the US. The recall was initiated on 20 Sep 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll lots impacted
Quantity recalled246 (US); 689 (OUS)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0181-2022
FDA event ID
88784
Recalling firm
Siemens Healthcare Diagnostics, Tarrytown, NY
Classification
Class II
Status
Ongoing
Recall initiated
20 Sep 2021
FDA classified
28 Oct 2021
Reported
3 Nov 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Device type
Spinal Implants

Timeline

20 Sep 2021Recall initiated by company
28 Oct 2021Classified by FDA+38 days
3 Nov 2021Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The firm has confirmed the potential for ADVIA Chemistry Urinary/Cerebrospinal Fluid Protein reagent carryover impacting Enzymatic Hemoglobin A1c (A1c_E and A1c_EM) results. Falsely depressed Enzymatic Hemoglobin A1c results may affect consideration of intervention.

Product as listed by the FDA

Advia Chemistry Urinary/Cerebrospinal Fluid Protein (UCFP), SMN 11319151

Where it was distributed

Worldwide distribution - US Nationwide distribution.

Nationwide

Questions about this recall

Why was it recalled?

The firm has confirmed the potential for ADVIA Chemistry Urinary/Cerebrospinal Fluid Protein reagent carryover impacting Enzymatic Hemoglobin A1c (A1c_E and A1c_EM) results. Falsely depressed Enzymatic Hemoglobin A1c results may affect consideration of intervention.

Which lots are affected?

All lots impacted

Where was it sold?

Worldwide distribution - US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 88784
ReportedClassRecallCompanyReasonWhere
CLASS IIAtellica CH Urinary/Cerebrospinal Fluid Protein (UCFP), SMN recalledSiemens Healthcare DiagnosticsOtherNationwide

More recalls from Siemens Healthcare Diagnostics

All 694

Other Spinal Implants recalls

All 1,157